Abstract
to analyze the production of scientific articles about the pharmacological and non-pharmacological management of delirium in adult hospitalized cancer patients. integrative review whose sample was obtained from the databases Scopus, Cumulative Index to Nursing and Allied Health Literature, EMBASE, Web of Science, and from the portals Biblioteca Virtual em Saúde, and PubMed. among the ten studies analyzed, 80% described exclusively the pharmacological management, especially with regard to the use of haloperidol; 20% mentioned, superficially, non-pharmacological interventions/actions (educational actions) associated to pharmacological management, and adjusting them could result in the diminution and control of psychomotor agitation, contributing for the safety and comfort of the patient. there are few studies addressing pharmacological and non-pharmacological interventions/actions to manage delirium. As a result, it is essential to develop studies focused on increasing and advancing scientific knowledge with regard to the theme, especially in the national context.
Highlights
According to the International Agency for Research on Cancer (IARC), from the World Health Organization (WHO), there were, throughout the world, 17 new million new cases of cancer, with a total of 9.42 million deaths in 2018(1)
It was conducted according to the following guiding question: “What are the interventions/ actions shown in literature for the pharmacological and nonpharmacological management of delirium in adult hospitalized cancer patients?”
The terms used were those related to the letters P - cancer patients hospitalized with delirium; I - interventions/actions conducted; C - there was no intervention for comparison; and O - delirium management
Summary
According to the International Agency for Research on Cancer (IARC), from the World Health Organization (WHO), there were, throughout the world, 17 new million new cases of cancer, with a total of 9.42 million deaths in 2018(1). Nonmelanoma skin cancer will be the most incident (177 thousand), followed by breast and prostate cancers (66 thousand cases each), colon and rectum cancer (41 thousand), lung cancer (30 thousand), and stomach cancer (21 thousand)(2). Most oncology patients, when in advanced stages, present with multiple symptoms, both physical and psychological, which produce a significant decline in their quality of life. These patients show an incredible diversity of symptoms related to the gravity and to the complications resulting from the progression of the disease and of antineoplastic therapies. Acute changes in cognitive functions, especially delirium, are prognostic of imminent death in oncology patients(3)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have